Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Allogene Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Allogene Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Allogene Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Allogene Therapeutics Inc
Numero di azioni emesse
221.881M
Azioni possedute dagli insider
14.707M
Percentuale posseduta dagli Insider
6.63%
Azioni possedute dagli investitori istituzionali
61.570M
Percentuale posseduta dagli investitori istituzionali
27.7%
Jun 12, 2025 | DIRECTOR | -36.88K | $1.42 | -$52.38K | SELL | -25.56% | 107.43K | Jun 10 | ||
Apr 23, 2025 | SVP, FINANCE | -9.60K | $1.41 | -$13.54K | SELL | -6.84% | 130.66K | Apr 21 | ||
Mar 18, 2025 | PRESIDENT AND CEO | -46.67K | $1.96 | -$91.47K | SELL | -0.72% | 6.48M | Mar 14 | ||
Mar 18, 2025 | SVP, CHIEF TECHNICAL OFFICER | -5.49K | $1.98 | -$10.84K | SELL | -2.45% | 218.51K | Mar 14 | ||
Feb 20, 2025 | DIRECTOR | -13.31K | $2.43 | -$32.35K | SELL | -8.45% | 144.32K | Feb 18 | ||
Feb 05, 2025 | SVP, GENERAL COUNSEL | -6.40K | $1.71 | -$10.95K | SELL | -1.08% | 587.85K | Feb 03 | ||
Feb 05, 2025 | CHIEF FINANCIAL OFFICER | -4.36K | $1.73 | -$7.54K | SELL | -0.33% | 1.30M | Feb 03 | ||
Feb 05, 2025 | CHIEF TECHNICAL OFFICER | -14.75K | $1.71 | -$25.22K | SELL | -5.55% | 250.71K | Feb 03 | ||
Feb 05, 2025 | PRESIDENT AND CEO | -46.00K | $1.68 | -$77.29K | SELL | -0.70% | 6.52M | Feb 03 | ||
Feb 05, 2025 | EVP R&D | -18.83K | $1.70 | -$32.01K | SELL | -2.84% | 643.13K | Feb 03 | ||
Jan 23, 2025 | EVP R&D | -27.20K | $1.78 | -$48.41K | SELL | -5.28% | 488.05K | Jan 21 | ||
Dec 10, 2024 | DIRECTOR | -9.14K | $2.18 | -$19.92K | SELL | -5.48% | 157.63K | Dec 09 | ||
Dec 09, 2024 | DIRECTOR | -9.22K | $2.16 | -$19.92K | SELL | -2.91% | 307.51K | Dec 05 | ||
Jun 20, 2024 | — | -18.64K | $2.28 | -$42.49K | SELL | -10.05% | 166.76K | Jun 18 | ||
Jun 03, 2024 | — | -11.20K | $2.34 | -$26.18K | SELL | -4.20% | 255.25K | May 30 | ||
May 20, 2024 | DIRECTOR | 2.07M | $2.90 | $6.00M | BUY | 142.36% | 3.52M | May 16 | ||
Mar 06, 2024 | CHIEF FINANCIAL OFFICER | 190.00 | $3.60 | $683.05 | BUY | 0.02% | 819.59K | Jan 30 | ||
Dec 20, 2023 | — | -18.64K | $2.70 | -$50.32K | SELL | -22.99% | 62.46K | Dec 18 | ||
Aug 09, 2023 | — | -10.00K | $4.29 | -$42.85K | SELL | -28.31% | 25.33K | Aug 07 | ||
Feb 14, 2023 | GENERAL COUNSEL | -3.00K | $6.85 | -$20.55K | SELL | -0.52% | 577.68K | Feb 13 | ||
Jan 18, 2023 | GENERAL COUNSEL | -3.00K | $7.04 | -$21.12K | SELL | -0.51% | 580.68K | Jan 17 | ||
Dec 19, 2022 | GENERAL COUNSEL | -5.60K | $7.53 | -$42.19K | SELL | -0.95% | 583.68K | Dec 15 | ||
Aug 15, 2022 | DIRECTOR | -15.00K | $16.75 | -$251.25K | SELL | -6.43% | 218.27K | Aug 11 - Aug 12 | ||
Aug 15, 2022 | DIRECTOR | -15.00K | $16.75 | -$251.25K | SELL | -6.43% | 218.27K | Aug 11 - Aug 12 | ||
Aug 02, 2022 | EVP R&D AND CMO | -2.00K | $11.97 | -$23.94K | SELL | -0.37% | 540.26K | Aug 02 | ||
Jul 06, 2022 | EVP R&D AND CMO | -2.00K | $11.44 | -$22.88K | SELL | -0.37% | 542.26K | Jul 05 | ||
Jun 23, 2022 | — | -10.00K | $11.76 | -$117.60K | SELL | -4.11% | 233.27K | Jun 22 | ||
Jun 22, 2022 | EVP R&D AND CMO | -2.00K | $11.18 | -$22.36K | SELL | -0.37% | 544.26K | Jun 21 | ||
May 19, 2022 | EVP R&D AND CMO | -11.50K | $7.40 | -$85.09K | SELL | -2.06% | 546.26K | May 19 | ||
Mar 17, 2022 | EVP R&D AND CMO | -5.17K | $7.71 | -$39.85K | SELL | -1.59% | 320.12K | Mar 15 | ||
Mar 17, 2022 | GENERAL COUNSEL | -8.85K | $7.68 | -$67.96K | SELL | -2.09% | 413.84K | Mar 15 | ||
Mar 17, 2022 | PRESIDENT AND CEO | -23.65K | $7.65 | -$180.88K | SELL | -0.75% | 3.15M | Mar 15 | ||
Mar 17, 2022 | CHIEF FINANCIAL OFFICER | -11.47K | $7.63 | -$87.55K | SELL | -0.91% | 1.25M | Mar 15 | ||
Mar 17, 2022 | CHIEF TECHNICAL OFFICER | -8.70K | $7.63 | -$66.39K | SELL | -6.74% | 120.43K | Mar 15 | ||
Jan 14, 2022 | — | 15.00K | $12.60 | $189.00K | BUY | 6.15% | 258.88K | Jan 12 | ||
Jan 14, 2022 | — | 155.04K | $12.60 | $1.95M | BUY | 3.26% | 4.91M | Jan 12 | ||
Oct 04, 2021 | EVP R&D AND CMO | -11.51K | $24.35 | -$280.19K | SELL | -3.43% | 323.93K | Oct 01 | ||
Sep 17, 2021 | GENERAL COUNSEL | 0.00 | $13.52 | -$112.49K | SELL-OPTIONS | 0.00% | 421.67K | Sep 15 | ||
Sep 09, 2021 | — | -5.00K | $25.54 | -$127.70K | SELL | -2.21% | 221.18K | Sep 09 | ||
Aug 23, 2021 | — | -10.00K | $23.47 | -$234.70K | SELL | -4.23% | 226.18K | Aug 20 | ||
Aug 17, 2021 | GENERAL COUNSEL | 0.00 | $11.63 | -$93.64K | SELL-OPTIONS | 0.00% | 421.35K | Aug 16 | ||
Jul 16, 2021 | GENERAL COUNSEL | 0.00 | $11.91 | -$96.40K | SELL-OPTIONS | 0.00% | 421.35K | Jul 15 | ||
Jun 16, 2021 | GENERAL COUNSEL | 0.00 | $13.79 | -$115.25K | SELL-OPTIONS | 0.00% | 421.35K | Jun 15 | ||
Jun 11, 2021 | — | -9.97K | $25.05 | -$249.72K | SELL | -4.05% | 236.18K | Jun 09 | ||
May 20, 2021 | GENERAL COUNSEL | 0.00 | $16.14 | -$138.65K | SELL-OPTIONS | 0.00% | 421.35K | May 18 | ||
May 17, 2021 | GENERAL COUNSEL | 0.00 | $15.28 | -$130.13K | SELL-OPTIONS | 0.00% | 421.35K | May 17 | ||
Apr 16, 2021 | GENERAL COUNSEL | 0.00 | $17.16 | -$297.82K | SELL-OPTIONS | 0.00% | 421.35K | Apr 15 | ||
Mar 17, 2021 | EVP R&D AND CMO | -2.80K | $38.05 | -$106.47K | SELL | -2.48% | 110.03K | Mar 15 | ||
Mar 17, 2021 | PRESIDENT AND CEO | -20.51K | $38.57 | -$791.27K | SELL | -0.71% | 2.85M | Mar 15 | ||
Mar 17, 2021 | CHIEF TECHNICAL OFFICER | -6.16K | $38.14 | -$235.09K | SELL | -5.67% | 102.57K | Mar 15 | ||
Mar 17, 2021 | GENERAL COUNSEL | -6.62K | $20.11 | -$608.10K | SELL | -1.63% | 399.15K | Mar 15 | ||
Mar 17, 2021 | CHIEF FINANCIAL OFFICER | -8.05K | $38.23 | -$307.89K | SELL | -0.65% | 1.22M | Mar 15 | ||
Jan 19, 2021 | CHIEF FINANCIAL OFFICER | -30.00K | $31.52 | -$945.47K | SELL | -2.38% | 1.23M | Jan 14 - Jan 15 | ||
Nov 18, 2020 | — | -15.00K | $32.88 | -$493.15K | SELL | -1.18% | 1.26M | Nov 16 | ||
Oct 16, 2020 | — | -15.00K | $40.49 | -$607.39K | SELL | -1.16% | 1.28M | Oct 15 | ||
Oct 13, 2020 | — | 0.00 | $22.14 | -$1.40M | OPTION EXERCISE | 0.00% | 108.37K | Oct 12 - Oct 13 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.